HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Clinical study of residual function and recurrences in patients after partial thyroidectomy for non-toxic nodular goiter]

AbstractThe different surgical chances for the treatment of non toxic nodular goiter led the Authors to study the residual function after partial thyroidectomy. A variable rate of recurrences and hormone deficiency was shown in patients who underwent sub-total thyroidectomy, lobectomy and enucleation. It depended on the amount of residual gland and the different methods they used. Recurrences occurred more in patients studied by ultrasonography. After sub-total thyroidectomy the Authors noted a more reduced number of recurrences than after lobectomy and enucleation. There was a meaningless connection between high plasmatic levels of TSH and recurrences. Subclinical hypothyroidism was higher in patients who underwent subtotal thyroidectomy than in patients treated with lobectomy and enucleation. These clinical data show that recurrences could depend on growth factors (EGF, IGF) in thyroid tissues and not only on TSH action. Therefore the surgical attitude of the authors in the treatment of nodular goiter consists in total thyroidectomy.
AuthorsA Ambrosi, A Pezzolla, G Barone, G Quaranta, D Errico, M Iacobone, A Ciampolillo, V Triggiani (Affiliation: Cattedra di Chirurgia Generale Base, Università degli Studi di Bari.)
JournalAnnali italiani di chirurgia (Ann Ital Chir) 1994 Sep-Oct Vol. 65 Issue 5 Pg. 543-6; discussion 546-7 ISSN: 0003-469X [Print] ITALY
Vernacular TitleStudio clinico della funzione residua e delle recidive in pazienti operati di tiroidectomie parziali per struma nodulare eutiroideo.
PMID7733577 (Publication Type: English Abstract, Journal Article)
Topics
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Recurrence
  • Thyroid Diseases (physiopathology, surgery)
  • Thyroid Gland (physiopathology, surgery)
  • Thyroidectomy (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD